Kahira Pharmaceuticals & Chemical Industries Company reported earnings results for the nine months ended March 31, 2023. For the nine months, the company reported sales was EGP 665.55 million compared to EGP 866.66 million a year ago. Net income was EGP 56.05 million compared to EGP 151.04 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
63.87 EGP | 0.00% | -9.06% | +12.94% |
1st Jan change | Capi. | |
---|---|---|
+12.94% | 19.91M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- CPCI Stock
- News Kahira Pharmaceuticals & Chemical Industries Company
- Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Nine Months Ended March 31, 2023